PDL BioPharma, Inc. ( PDLI ) will begin trading ex-dividend on June 03, 2014. A cash dividend payment of $0.15 per share is scheduled to be paid on June 12, 2014. Shareholders who purchased PDLI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 16th quarter that PDLI has paid the same dividend. At the current stock price of $9.37, the dividend yield is 6.4%.
The previous trading day's last sale of PDLI was $9.37, representing a -8.18% decrease from the 52 week high of $10.21 and a 26.96% increase over the 52 week low of $7.38.
PDLI is a part of the Health Care sector, which includes companies such as Gilead Sciences, Inc. ( GILD ) and Amgen Inc. ( AMGN ). PDLI's current earnings per share, an indicator of a company's profitability, is $1.81. Zacks Investment Research reports PDLI's forecasted earnings growth in 2014 as 24.1%, compared to an industry average of 11.9%.
Interested in gaining exposure to PDLI through an Exchange Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:
- First Trust DJ Global Select Dividend ( FGD )
- WisdomTree SmallCap Earnings Fund ( EES )
- WisdomTree Trust SmallCap Dividend Fund ( DES ).
The top-performing ETF of this group is FGD with an increase of 9.76% over the last 100 days. It also has the highest percent weighting of PDLI at 1.28%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.